FDA Clears Phadia’s Allergy Test, ImmunoCAP Rapid Reader II
Phadia announces that FDA has cleared the ImmunoCAP Rapid Reader II, a part of the ImmunoCAP Rapid System, used to aid in the diagnosis of allergy in the physicians office.
Read MorePhadia announces that FDA has cleared the ImmunoCAP Rapid Reader II, a part of the ImmunoCAP Rapid System, used to aid in the diagnosis of allergy in the physicians office.
Read MoreStepped-up vaccination requirements, a boost in resources for prevention and treatment, and a public awareness campaign similar to the effort that dispelled the stigma of HIV/AIDS are needed to curb the health threats posed by hepatitis B and hepatitis C, says a new report from the Institute of Medicine.
Read MoreAbbott announced today it has submitted a Premarket Approval application to the US FDA for the ARCHITECT HIV Ag/Ab Combo test.
Read MoreThrough collaborative efforts with multiple industry partners, Celerus Diagnostics has successfully demonstrated Rapid ISH (in-situ hybridization) on its forthcoming Wave RPD System.
Read MoreDaxor Corporation, a medical instrumentation and biotechnology company, announced that five major research reports derived from studies using the Daxor Blood Volume Analyzer (BVA-100) were presented at the annual Society of Critical Care Medicine (SCCM) conference in Miami, FL.
Read More